FNDC5 and type 2 diabetes mellitus: All these highlighted that irisin had an underlying function as a biomarker or modulator of bone abnormalities in the T2DM patient group where they are more susceptible to fracture which was suggested to be considered one of the chronic complications of T2DM [12–14].